RT Journal Article
SR Electronic
T1 Myasthenia gravis: Newer therapies offer sustained improvement
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 711
OP 721
DO 10.3949/ccjm.80a.13044
VO 80
IS 11
A1 Li, Yuebing
A1 Arora, Yeeshu
A1 Levin, Kerry
YR 2013
UL http://www.ccjm.org/content/80/11/711.abstract
AB Myasthenia gravis is a prototypical antibody-mediated autoimmune neuromuscular disorder. Treatments have improved over the past 30 years, leading to significantly fewer deaths and better quality of life. Future research should further elucidate its pathogenesis, reveal better ways to diagnose it, and yield new treatments.